Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound-Reference-Cited by-同舟云学术

Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound

Published:2022-09 Issue:3 Volume:82 Page:261-270
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ertl Iris E.,Lemberger Ursula,Ilijazi Dafina,Hassler Melanie R.,Bruchbacher Andreas,Brettner Robert,Kronabitter Hannah,Gutmann Michael,Vician Petra,Zeitler Gerhard,Koren Anna,Lardeau Charles-Hugues,Mohr Thomas,Haitel Andrea,Compérat Eva,Oszwald André,Wasinger Gabriel,Clozel Thomas,Elemento Olivier,Kubicek Stefan,Berger Walter,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The health economics of bladder cancer: an updated review of the published literature;Yeung;Pharmacoeconomics,2014

3. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy;Choi;Cancer Cell,2014

4. ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers;Kamat;Eur Urol,2013

5. Human biodistribution and radiation dosimetry of 18F-clofarabine, a PET probe targeting the deoxyribonucleoside salvage pathway;Barrio;J Nucl Med,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovating cancer drug discovery with refined phenotypic screens;Trends in Pharmacological Sciences;2024-08

2. A systematic review on diagnostic and prognostic biomarkers for bladder cancer;2024-06-03

3. Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models;European Urology Oncology;2024-05

4. Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine;Current Opinion in Urology;2024-04-10

5. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor;Journal of Experimental & Clinical Cancer Research;2024-01-20